Cargando…
Can the host immune response against SARS-CoV2 also cause an anticancer effect?
During the COVID-19 pandemic, it is important to assure the safety and management of cancer patients. Despite preliminary studies revealed that patients with cancer are more susceptible to infection and have poorer prognosis than other infected patients without cancer, mortality from COVID-19 in can...
Autores principales: | Kahraman, Seda, Akinci, Muhammed Bulent, Sendur, Mehmet Ali Nahit, Yalcin, Bulent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243040/ https://www.ncbi.nlm.nih.gov/pubmed/34191146 http://dx.doi.org/10.1007/s12032-021-01533-7 |
Ejemplares similares
-
How the algorithms can change during the COVID-19 pandemic: A case of primary hyperaldosteronism
por: Iremli, Burcin Gonul, et al.
Publicado: (2023) -
RETRACTED ARTICLE: Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors
por: Guler, Ferhan, et al.
Publicado: (2022) -
Acute Charcot neuropathy: A devastating consequence of diabetes mellitus
por: Iremli, Burcin Gonul, et al.
Publicado: (2023) -
Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression
por: Tatli Dogan, Hayriye, et al.
Publicado: (2018) -
COVID-19 vaccination and thyroiditis
por: Şendur, Süleyman Nahit, et al.
Publicado: (2023)